Photo of Margareta Holmström

Margareta Holmström

Senior Associate Professor, Head of Division, Head of Unit

Publications

2024

David E. Schmidt, Asa Truedsson, Annelie Stralfors, Johanne Andersen Hojbjerg, Nida Soutari, Margareta Holmström, Susanna Ranta, Anna Letelier, Annette Bowyer, Rolf Ljung, Jovan Antovic, Maria Bruzelius (2024) Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B Thrombosis and Haemostasis, Vol. 124, p. 032-039 Continue to DOI

2023

Anna Olsson, Linda Myrin Westesson, Fariba Baghaei, Margareta Holmström, Elsa Olsson, Maria Magnusson, Susanna Ranta, Jan Astermark, Nadine G. G. Andersson, Judith Thanner, Johan Szamosi, Loudin Daoura, Karin Sennfaelt (2023) Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders Haemophilia, Vol. 29, p. 377-381 Continue to DOI
Katarina Steen Carlsson, Bent Winding, Jan Astermark, Fariba Baghaei, Elisabeth Brodin, Eva Funding, Margareta Holmström, Klaus Osterholm, Sofia Bergenstrale, Stefan Lethagen (2023) High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, Vol. 7, Article e100061 Continue to DOI
Bjorn Lundin, Fariba Baghaei, Margareta Holmström, Pia Petrini, Gunilla Mueller, Sven Mansson, Rolf Ljung (2023) Haemophilia A and B - evaluation of the Swedish prophylactic regimen by magnetic resonance imaging Haemophilia, Vol. 29, p. 193-198 Continue to DOI

2022

Pratima Chowdary, Margareta Holmström, Johnny N. Mahlangu, Margaret C. Ozelo, Ingrid Pabinger, K. John Pasi, Margaret V Ragni, Amy Shapiro, Chris Barnowski, Stefan Lethagen (2022) Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies Research and Practice in Thrombosis and Haemostasis, Vol. 6, Article e12760 Continue to DOI

Research